Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Grant, Augustus O.
Jumbo Large Regular Text:
Print
Physicians

Augustus O. Grant, PhD, MB ChB

Related Content

Locations

  • Duke Cardiology Consult Clinic

Services

  • Adjunctive Therapy for Heart Failure
  • Atrial Fibrillation
  • Cardiovascular Genetics Services
  • Duke Center for Atrial Fibrillation
  • Sudden Cardiac Arrest Prevention, Implantable Defibrillators, and Ventricular Tachycardia

Share

Augustus O. Grant, PhD, MB ChB

Vice Dean, for Faculty Enrichment

Department / Division
Medicine / Medicine - Cardiology

Address
DUMC 3504
Durham, NC 27710

Appointment Telephone
919-684-3901

Office Telephone
919-684-5948

Fax Telephone
919-681-8978

Training
  • MB ChB, University of Edinburgh (Scotland), 1971

Residency
  • Internal Medicine, University of Manitoba (Canada), 1975-1977
  • Cardiology, Duke University Medical Center, 1977-1980

Other Training
  • PhD, Pharmacology, University of California, San Francisco, 1972-1975

Clinical Interests
Cardiac arrhythmias

Research Interests

This laboratory seeks to understand the molecular events that control excitation in cardiac muscle and the mechanisms by which excitation is modified by drugs. The experimental models include the isolated cardiac myocyte, the frog oocyte and mammalian cells expressing mRNA transcripts of wild-type and mutant channels. The experimental techniques include DNA and RNA manipulation, whole cell voltage clamping and the extracellular patch clamping. The current focus of the laboratory is the voltage gated sodium channel. The problems under study include:

1) The functional effects of the derangements occurring during
myocardial ischemia on channel function.
2) The mechanisms of blockade of channels by antiarrhythmic drugs.
3) The relationship between channel structure and antiarrhythmic drug
binding.
4) The development of models to describe the interaction of anti-
arrhythmic drugs with membrane channels.

These studies should provide a clearer understanding of the cellular basis of cardiac arrhythmias and the mechanisms by which they are terminated by drug.

Industry Relationships and Collaborations (What's this?)

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

  • Pfizer Inc.
  • Sanofi-Aventis
  • Unilever plc
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Dec. 12, 2006
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/augustus_o_grant